Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL)

Market Closed
17 Aug, 20:00
NYSE NYSE
$
286. 64
+6.59
+2.3532%
Pre Market
$
297. 74
+11.1 +3.8725%
13.55B Market Cap
- P/E Ratio
- Div Yield
856,790 Volume
- Eps
$ 280.05
Previous Close
Add Transaction
Day Range
279.37 288.88
Year Range
144.26 288.88
Want to track CRL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Charles River Laboratories International, Inc. (CRL) Statistics

Valuation metrics

Market Cap 13.55B
Enterprise value 16.33B
Trailing P/E (ttm) -57.86
Forward P/E 12.46
PEG ratio 0.6
Price/Sales (ttm) 3.37
Price/Book (mrq) 4.78
Enterprise Value/Revenue 4.08
Enterprise Value/EBITDA 74.05

Overview

Shares outstanding 49.22M
Float 48.66M
Shares short 3.54M
% Held by insiders 0.01%
% Held by institutions 1.1%
Average volume (10 days) 964.95K
Average volume (90 days) 969.65K

Price summary

52-Week low 144.26
52-Week high 288.88
Beta 1.65
50-Day moving average 242.7
200-Day moving average 186.41

Financials

Fiscal year

Fiscal year ends 27 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -0.06%
Operating margin 0.12%

Operational effectiveness

Return on assets -0.03%
Return on equity -0.08%

Income Statement

Revenue (ttm) 4.02B
Revenue per share (ttm) 82.48
Quarterly revenue growth (yoy) -0.01%
Gross profit (ttm) 1.4B
EBITDA 786.81M
Net income to common (ttm) -144.34M
Diluted EPS (ttm) -4.92
Quarterly earnings growth (yoy) -0.01%

Balance Sheet

Total cash (mrq) 213.77M
Total cash per share (mrq) 3.96
Total debt (mrq) 2.63B
Total Debt/Equity (mrq) 1.07
Current ratio (mrq) 1.35%
Book value per share (mrq) 58.7

Cash Flow

Cash flow statement 737.65M
Levered free cash flow (LFCF) 572.38M